Integrated bioinformatic analysis for the identification of potential biomarkers of kidney damage in hyperoxaluria

Q2 Pharmacology, Toxicology and Pharmaceutics
U. Adiga, Shreyas Adiga, T.M. Desy, N. Honnalli, Tirthal Rai
{"title":"Integrated bioinformatic analysis for the identification of potential biomarkers of kidney damage in hyperoxaluria","authors":"U. Adiga, Shreyas Adiga, T.M. Desy, N. Honnalli, Tirthal Rai","doi":"10.7324/japs.2023.137646","DOIUrl":null,"url":null,"abstract":"Hyperoxaluria is described by an augmented urinary elimination of oxalate. Systemic oxalosis is the term for the condition that occurs when the burden of calcium oxalate (CaOx) surpasses the renal capacity to excrete it. When individuals acquire chronic renal disease, elevated urinary oxalate levels aid in diagnosis, whereas plasma oxalate levels are probably more reliable. Based on bioinformatic analysis, the study aimed to identify differentially expressed genes (DEGs) and miRNA as potential biomarkers to differentiate normal versus hyperoxaluric state compared to the stage of CaOx crystals in the kidney. Published microarray data for gene expression patterns of normal controls, hyperoxaluric kidney tissue, and kidney tissue at the stage of crystal formation were collected from the National Center for Biotechnology Information Gene Expression Omnibus database. Integrated bioinformatics methods were utilized to analyze and compare these gene expression patterns. The data processing was conducted using R software. Gene ontology and the Kyoto Encyclopedia of Genes and Genomes database were employed to explore the enrichment of pathways and functions in the DEGs. Additionally, the STRING database was utilized to investigate protein–protein interactions. Tarbase, Mirnda, and DIANA software were used to obtain miRNAs for the top 10 DEGs. A total of 62,966 genes were screened, 2,814 were differentially expressed, out of which 603 genes were statistically significantly differentially expressed, after analyzing the GSE89028 dataset. A total of 2,810 genes were downregulated and only 4 genes were upregulated on day 14. The genes Cdt1 and cdhr4 were highly significantly differentiated with log2 (fold change) being −3.085 and −3.966, respectively, −log 10 ( p -value) being 6.857 and 6.196, respectively, at 14 days. On day 28, 62,976 genes were screened, out of which 356 were significantly differentiated. Only four genes were upregulated and 240 genes were downregulated. Csmd1, Olr154, Cntfr, Zbtb16 log2 (fold change) being 1.188, 1.527, 1.782, and 2.636, respectively; −log 10 ( p -value) being 4.071, 3.804, 4.357, and 4.061, respectively. The text mining evidence was observed on string analysis in both the contexts. The strength of alternative splicing (cellular enrichment) was 1.16 with a false discovery rate of 0.0409. The study showcases the effectiveness of bioinformatics analytical methods in pinpointing potential pathogenic genes associated with hyperoxaluria and the deposition of crystals in the kidneys. The interaction network identified two miRNAs, hsa-miR-6884-5p and hsa-miR-4653-5p, and two genes CDHR4 and EGR2 as significant players.","PeriodicalId":15126,"journal":{"name":"journal of applied pharmaceutical science","volume":"82 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"journal of applied pharmaceutical science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7324/japs.2023.137646","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Hyperoxaluria is described by an augmented urinary elimination of oxalate. Systemic oxalosis is the term for the condition that occurs when the burden of calcium oxalate (CaOx) surpasses the renal capacity to excrete it. When individuals acquire chronic renal disease, elevated urinary oxalate levels aid in diagnosis, whereas plasma oxalate levels are probably more reliable. Based on bioinformatic analysis, the study aimed to identify differentially expressed genes (DEGs) and miRNA as potential biomarkers to differentiate normal versus hyperoxaluric state compared to the stage of CaOx crystals in the kidney. Published microarray data for gene expression patterns of normal controls, hyperoxaluric kidney tissue, and kidney tissue at the stage of crystal formation were collected from the National Center for Biotechnology Information Gene Expression Omnibus database. Integrated bioinformatics methods were utilized to analyze and compare these gene expression patterns. The data processing was conducted using R software. Gene ontology and the Kyoto Encyclopedia of Genes and Genomes database were employed to explore the enrichment of pathways and functions in the DEGs. Additionally, the STRING database was utilized to investigate protein–protein interactions. Tarbase, Mirnda, and DIANA software were used to obtain miRNAs for the top 10 DEGs. A total of 62,966 genes were screened, 2,814 were differentially expressed, out of which 603 genes were statistically significantly differentially expressed, after analyzing the GSE89028 dataset. A total of 2,810 genes were downregulated and only 4 genes were upregulated on day 14. The genes Cdt1 and cdhr4 were highly significantly differentiated with log2 (fold change) being −3.085 and −3.966, respectively, −log 10 ( p -value) being 6.857 and 6.196, respectively, at 14 days. On day 28, 62,976 genes were screened, out of which 356 were significantly differentiated. Only four genes were upregulated and 240 genes were downregulated. Csmd1, Olr154, Cntfr, Zbtb16 log2 (fold change) being 1.188, 1.527, 1.782, and 2.636, respectively; −log 10 ( p -value) being 4.071, 3.804, 4.357, and 4.061, respectively. The text mining evidence was observed on string analysis in both the contexts. The strength of alternative splicing (cellular enrichment) was 1.16 with a false discovery rate of 0.0409. The study showcases the effectiveness of bioinformatics analytical methods in pinpointing potential pathogenic genes associated with hyperoxaluria and the deposition of crystals in the kidneys. The interaction network identified two miRNAs, hsa-miR-6884-5p and hsa-miR-4653-5p, and two genes CDHR4 and EGR2 as significant players.
综合生物信息学分析鉴定高血氧症肾脏损害的潜在生物标志物
高草酸尿表现为尿液中草酸的清除增加。系统性草酸中毒是指当草酸钙(CaOx)的负荷超过肾脏排泄能力时发生的情况。当个体患有慢性肾脏疾病时,尿草酸水平升高有助于诊断,而血浆草酸水平可能更可靠。基于生物信息学分析,该研究旨在鉴定差异表达基因(DEGs)和miRNA作为潜在的生物标志物,以区分肾脏CaOx晶体阶段的正常与高血氧状态。已发表的正常对照、高血氧肾组织和晶体形成阶段肾组织基因表达模式的微阵列数据来自国家生物技术信息中心基因表达综合数据库。利用综合生物信息学方法对这些基因表达模式进行分析和比较。数据处理采用R软件进行。利用基因本体和《京都基因与基因组百科全书》数据库来探索基因变异基因中富集的途径和功能。此外,STRING数据库被用于研究蛋白质之间的相互作用。使用Tarbase, Mirnda和DIANA软件获取前10个deg的mirna。通过对GSE89028数据集的分析,共筛选到62966个基因,其中2814个基因差异表达,其中603个基因差异表达具有统计学意义。在第14天,共有2810个基因被下调,只有4个基因被上调。Cdt1和cdhr4基因分化高度显著,14 d时log2 (fold change)分别为- 3.085和- 3.966,log10 (p -value)分别为6.857和6.196。第28天,筛选到62976个基因,其中356个显著分化。只有4个基因上调,240个基因下调。Csmd1、Olr154、Cntfr、Zbtb16的log2 (fold change)分别为1.188、1.527、1.782、2.636;−log10 (p -value)分别为4.071、3.804、4.357、4.061。在两种情况下的字符串分析中观察到文本挖掘证据。选择性剪接强度(细胞富集)为1.16,错误发现率为0.0409。该研究展示了生物信息学分析方法在确定与高草酸尿和肾脏晶体沉积相关的潜在致病基因方面的有效性。相互作用网络确定了两个mirna, hsa-miR-6884-5p和hsa-miR-4653-5p,以及两个基因CDHR4和EGR2是重要的参与者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
journal of applied pharmaceutical science
journal of applied pharmaceutical science Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
2.20
自引率
0.00%
发文量
224
期刊介绍: Journal of Applied Pharmaceutical Science (JAPS) is a monthly, international, open access, journal dedicated to various disciplines of pharmaceutical and allied sciences. JAPS publishes manuscripts (Original research and review articles Mini-reviews, Short communication) on original work, either experimental or theoretical in the following areas; Pharmaceutics & Biopharmaceutics Novel & Targeted Drug Delivery Nanotechnology & Nanomedicine Pharmaceutical Chemistry Pharmacognosy & Ethnobotany Phytochemistry Pharmacology & Toxicology Pharmaceutical Biotechnology & Microbiology Pharmacy practice & Hospital Pharmacy Pharmacogenomics Pharmacovigilance Natural Product Research Drug Regulatory Affairs Case Study & Full clinical trials Biomaterials & Bioactive polymers Analytical Chemistry Physical Pharmacy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信